strong result larg in-lin
expect
report result in-lin expect revenu
million revenu grew organ
ep consensu expect
grow howev entir beat model
due lower expect tax rate stock option exercis
over-year billion miss consensu billion in-lin
estim subscript rate grew organ report
analyt report organ run rate growth flattish growth asset-
base fee abf expect given tough aum comp index
rate grew organ rate includ esg
impress net new recur sale new recur sale million
better
asset base fee abf revenu shrunk compar result
lower averag aum year-over-year basi averag abf fee
declin bp year-over-year bp sequenti result product mix
fee compress market appreci asset flow abf
return posit growth
revenu growth across board revenu grew organ
year-over-year analyt revenu grew organ
grew led strong perform esg
increment invest continu throughout manag
guid higher side ebitda expens rang due
increment invest gener addit growth
outlook rais revenu estim million
million decreas ep estim
revenu estim remain billion ep estim increas
due beat run rate estim
maintain billion
total debt total asset
share current trade ep estim
compar histor rang averag ntm price-to-earnings
continu like long-term prospect compani reiter
neutral rate see enough upsid built current valuat
share current price perfect admittedli compani execut
past sever year close perfect one expect
import pleas read disclosur disclaim page report
quarterli incom statement million
servic
revenu
revenu
sell market
revenu
revenu
revenu
amort intang asset
revenu
depreci amort ppe
revenu
revenu
revenu
revenu
incom incom taxes- continu
revenu
net incom continu oper
revenu
earn per dilut common share cont op
revenu
reconcili adjust net income/ep
 net incom continu op
amort intang asset
less gain divestiture/invest
debt repay refinanc
tax reform adj /tax impact pend transact
amort intang asset
